Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A novel macromolecular prodrug concept exploiting endogenous serum albumin as a drug carrier for cancer chemotherapy.

× No keyword cloud information.

31 in total

1. Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy.

Authors: U Beyer; B Rothern-Rutishauser; C Unger; H Wunderli-Allenspach; F Kratz
Journal: Pharm Res Date: 2001-01 Impact factor: 4.200

Review 2. Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors: Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal: Pharm Res Date: 2002-05 Impact factor: 4.200

Review 3. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors: K Oettl; R E Stauber
Journal: Br J Pharmacol Date: 2007-04-30 Impact factor: 8.739

Review 4. Objective: tumor. Strategies of drug targeting at the tumor mass level.

Authors: C Martín Sabroso; A I Torres-Suárez
Journal: Clin Transl Oncol Date: 2013-07-12 Impact factor: 3.405

5. Albumin-binding domain conjugate for near-infrared fluorescence lymphatic imaging.

Authors: Cynthia A Davies-Venn; Bonnie Angermiller; Nathaniel Wilganowski; Pradip Ghosh; Barrett R Harvey; Grace Wu; Sunkuk Kwon; Melissa B Aldrich; Eva M Sevick-Muraca
Journal: Mol Imaging Biol Date: 2012-06 Impact factor: 3.488

6. A new class of recombinant human albumin with multiple surface thiols exhibits stable conjugation and enhanced FcRn binding and blood circulation.

Authors: Karen Kræmmer Schelde; Karl Nicholls; Frederik Dagnæs-Hansen; Karen Bunting; Helen Rawsthorne; Birgitte Andersen; Christopher J A Finnis; Miranda Williamson; Jason Cameron; Kenneth A Howard
Journal: J Biol Chem Date: 2019-01-02 Impact factor: 5.157

7. INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model.

Authors: R Graeser; N Esser; H Unger; I Fichtner; A Zhu; C Unger; F Kratz
Journal: Invest New Drugs Date: 2009-01-08 Impact factor: 3.850

8. Albumin-Oxanorbornadiene Conjugates Formed ex Vivo for the Extended Circulation of Hydrophilic Cargo.

Authors: Cody J Higginson; Marsha R Eno; Susan Khan; Michael D Cameron; M G Finn
Journal: ACS Chem Biol Date: 2016-06-27 Impact factor: 5.100

9. Synthesis and biological properties of oxazolinodaunorubicin--a new derivative of daunorubicin with a modified daunosamine moiety.

Authors: Malgorzata Lukawska; Joanna Wietrzyk; Adam Opolski; Janusz Oszczapowicz; Irena Oszczapowicz
Journal: Invest New Drugs Date: 2009-08-28 Impact factor: 3.850

Review 10. Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Authors: Zhibo Liu; Xiaoyuan Chen
Journal: Chem Soc Rev Date: 2016-03-07 Impact factor: 54.564